Milestone Pharmaceuticals Inc (MIST) insider trading
Every open-market stock purchase and sale by Milestone Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1.2M over the last 12 months (7 sales). No open-market buys.
- Last insider buy: David Bharucha (C-suite exec), $32.8K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.2M (7 sales). Last close $1.23 on Jun 4, 2026.
Recent MIST insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | Robert James Wills (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Andrew Saik (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Michael John Tomsicek (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Stuart Duty (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Seth H. Z. Fischer (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Lisa M. Giles (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Joseph C Papa (Insider) | Bought (not open market) | — |
| Apr 16, 2026 | Joseph Oliveto (CEO) | Sold | $82.5K |
| Feb 2, 2026 | Amit Hasija (CFO) | Bought (not open market) | — |
| Feb 2, 2026 | Lorenz Muller (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Joseph Oliveto (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Joseph Oliveto (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Amit Hasija (CFO) | Bought (not open market) | — |
| Feb 2, 2026 | David Bharucha (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | David Bharucha (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Lorenz Muller (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Jeffrey Edward Nelson (COO) | Bought (not open market) | — |
| Feb 2, 2026 | Jeffrey Edward Nelson (COO) | Bought (not open market) | — |
| Feb 2, 2026 | Joseph Oliveto (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Amit Hasija (CFO) | Bought (not open market) | — |
| Feb 2, 2026 | David Bharucha (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Jeffrey Edward Nelson (COO) | Bought (not open market) | — |
| Feb 2, 2026 | Lorenz Muller (C-suite exec) | Bought (not open market) | — |
| Jan 26, 2026 | Joseph Oliveto (CEO) | Sold | $66.6K |
| Jan 26, 2026 | David Bharucha (C-suite exec) | Sold | $23.6K |
Who's trading MIST
- Lisa M. Giles, Insider: other filings, last Jun 10, 2026
- Joseph C Papa, Insider: other filings, last Jun 10, 2026
- Andrew Saik, Insider: other filings, last Jun 10, 2026
- Michael John Tomsicek, Insider: other filings, last Jun 10, 2026
- Stuart Duty, Insider: other filings, last Jun 10, 2026
- Robert James Wills, Insider: other filings, last Jun 10, 2026
- Seth H. Z. Fischer, Insider: other filings, last Jun 10, 2026
- Joseph Oliveto, CEO: sold $556K (5 sales), last Apr 16, 2026
- Lorenz Muller, C-suite exec: sold $146K (2 sales), last Feb 2, 2026
- Amit Hasija, CFO: sold $158K (2 sales), last Feb 2, 2026
- David Bharucha, C-suite exec: sold $158K (2 sales), last Feb 2, 2026
- Jeffrey Edward Nelson, COO: sold $158K (2 sales), last Feb 2, 2026
Get free alerts when an insider at Milestone Pharmaceuticals Inc files a new trade →